QUEBEC CITY, Jan. 17, 2019 /CNW Telbec/ - It is with great sadness that Endoceutics management announces the death of its president and founder Dr. Fernand Labrie at the age of 81.
Dr. Labrie, a graduate of the Faculty of Medicine of Université Laval, also studied at the University of Cambridge in the U.K. He dedicated the bulk of his career to studying the mechanism of hormone action. He founded the Laboratory of Molecular Endocrinology at Université Laval, which he directed for 40 years. His research led to important discoveries in the treatment of prostate cancer. Over the course of his prolific career, Dr. Labrie headed the CHUL (Centre hospitalier de l'Université Laval) Research Centre and published over 1,200 scientific articles. More recently, he had turned his attention to women's health issues. In 2006 he founded Endoceutics, which today develops and commercializes treatments for the symptoms of menopause.
Dr. Labrie received numerous awards and distinctions over the course of his career, including the Prince of Wales Award, the Medal of the Governor General of Canada, Officer of the Order of Canada, the Queen's Diamond Jubilee Medal, and Professor Emeritus of Université Laval.
Endoceutics is very proud of Dr. Labrie's many accomplishments and intends to pursue his work and mission.
Dr. Labrie's family wishes to mourn in private and will not be granting interviews.
For further information: Pamela Champagne-Côté, Tact Intelligence-conseil, firstname.lastname@example.org, 418-529-3223 ext. 244